WO1998024905A3 - Secreted proteins and polynucleotides encoding them - Google Patents
Secreted proteins and polynucleotides encoding them Download PDFInfo
- Publication number
- WO1998024905A3 WO1998024905A3 PCT/US1997/022211 US9722211W WO9824905A3 WO 1998024905 A3 WO1998024905 A3 WO 1998024905A3 US 9722211 W US9722211 W US 9722211W WO 9824905 A3 WO9824905 A3 WO 9824905A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polynucleotides encoding
- secreted proteins
- proteins
- secreted
- polynucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002273845A CA2273845A1 (en) | 1996-12-06 | 1997-12-05 | Secreted proteins and polynucleotides encoding them |
AU55164/98A AU5516498A (en) | 1996-12-06 | 1997-12-05 | Secreted proteins and polynucleotides encoding them |
EP97951549A EP0948620A2 (en) | 1996-12-06 | 1997-12-05 | Secreted proteins and polynucleotides encoding them |
JP52578598A JP2002512503A (en) | 1996-12-06 | 1997-12-05 | Secreted proteins and polynucleotides encoding them |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76221696A | 1996-12-06 | 1996-12-06 | |
US08/762,216 | 1996-12-06 | ||
US98451697A | 1997-12-03 | 1997-12-03 | |
US08/984,516 | 1997-12-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998024905A2 WO1998024905A2 (en) | 1998-06-11 |
WO1998024905A3 true WO1998024905A3 (en) | 1998-09-17 |
Family
ID=27117092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/022211 WO1998024905A2 (en) | 1996-12-06 | 1997-12-05 | Secreted proteins and polynucleotides encoding them |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0948620A2 (en) |
JP (1) | JP2002512503A (en) |
AU (1) | AU5516498A (en) |
CA (1) | CA2273845A1 (en) |
WO (1) | WO1998024905A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000050592A1 (en) * | 1999-02-24 | 2000-08-31 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
US20020146692A1 (en) * | 2000-01-21 | 2002-10-10 | Victoria Yamazaki | Methods and materials relating to G protein-coupled receptor-like polypeptides and polynucleotides |
AU2002247679A1 (en) * | 2001-02-05 | 2002-09-19 | Bayer Aktiengesellschaft | A human member of the phospholipase d superfamily and methods for regulating its activity |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005780A1 (en) * | 1988-11-18 | 1990-05-31 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Dopamine receptors and genes |
WO1990014432A1 (en) * | 1989-05-23 | 1990-11-29 | Genetics Institute, Inc. | A human cytokine, interleukin-9 |
EP0510691A1 (en) * | 1991-04-26 | 1992-10-28 | Osaka Bioscience Institute | DNA coding for human cell surface antigen |
WO1994007916A1 (en) * | 1992-10-07 | 1994-04-14 | Merck & Co., Inc. | Human steroid hormone receptor neri |
WO1996017925A1 (en) * | 1994-12-06 | 1996-06-13 | Immunex Corporation | Cytokine designated lerk-7 |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1997025427A1 (en) * | 1996-01-12 | 1997-07-17 | Genetics Institute, Inc. | Beta-chemokine, h1305 (mcp-2) |
WO1997044356A2 (en) * | 1996-05-08 | 1997-11-27 | Biogen, Inc. | RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
-
1997
- 1997-12-05 CA CA002273845A patent/CA2273845A1/en not_active Abandoned
- 1997-12-05 JP JP52578598A patent/JP2002512503A/en active Pending
- 1997-12-05 WO PCT/US1997/022211 patent/WO1998024905A2/en not_active Application Discontinuation
- 1997-12-05 EP EP97951549A patent/EP0948620A2/en not_active Withdrawn
- 1997-12-05 AU AU55164/98A patent/AU5516498A/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005780A1 (en) * | 1988-11-18 | 1990-05-31 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Dopamine receptors and genes |
WO1990014432A1 (en) * | 1989-05-23 | 1990-11-29 | Genetics Institute, Inc. | A human cytokine, interleukin-9 |
EP0510691A1 (en) * | 1991-04-26 | 1992-10-28 | Osaka Bioscience Institute | DNA coding for human cell surface antigen |
WO1994007916A1 (en) * | 1992-10-07 | 1994-04-14 | Merck & Co., Inc. | Human steroid hormone receptor neri |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO1996017925A1 (en) * | 1994-12-06 | 1996-06-13 | Immunex Corporation | Cytokine designated lerk-7 |
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1997025427A1 (en) * | 1996-01-12 | 1997-07-17 | Genetics Institute, Inc. | Beta-chemokine, h1305 (mcp-2) |
WO1997044356A2 (en) * | 1996-05-08 | 1997-11-27 | Biogen, Inc. | RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
Non-Patent Citations (6)
Title |
---|
ADAMS M D ET AL: "3,400 NEW EXPRESSED SEQUENCE TAGS IDENTIFY DIVERSITY OF TRANSCRIPTS IN HUMAN BRAIN", NATURE GENETICS, vol. 4, no. 3, pages 256 - 267, XP000611495 * |
JACOBS K ET AL: "A novel method for isolating eukaryotic cDNA clones encoding secreted proteins.", KEYSTONE SYMPOSIUM ON DENDRITIC CELLS: ANTIGEN PRESENTING CELLS OF T AND B LYMPHOCYTES, TAOS, NEW MEXICO, USA, MARCH 10-16, 1995. JOURNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT 0 (21A). 1995. 19. ISSN: 0733-1959, XP002027246 * |
M. SANICOLA ET AL.: "Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins", PROC. NATL. ACAD. SCI., vol. 94, no. 12, June 1997 (1997-06-01), NATL. ACAD. SCI.,WASHINGTON,DC,US;, pages 6238 - 6243, XP002059966 * |
R.J. KAUFMAN ET AL.: "Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in chinese hamster ovary cells", MOL. CELL. BIOL., vol. 9, no. 3, March 1989 (1989-03-01), ASM WASHINGTON, DC,US, pages 1233 - 1242, XP002041592 * |
R.J. KAUFMAN ET AL.: "Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus", NUCLEIC ACIDS RESEARCH, vol. 19, no. 16, 1991, IRL PRESS LIMITED,OXFORD,ENGLAND, pages 4485 - 4490, XP002041594 * |
R.J. KAUFMAN ET AL.: "The phosphorylation state of eucaryotic initiation factor 2 alters translation efficiency of specific mRNAs", MOL. CELL. BIOL., vol. 9, no. 3, March 1989 (1989-03-01), ASM WASHINGTON, DC,US, pages 946 - 958, XP002041593 * |
Also Published As
Publication number | Publication date |
---|---|
CA2273845A1 (en) | 1998-06-11 |
AU5516498A (en) | 1998-06-29 |
EP0948620A2 (en) | 1999-10-13 |
JP2002512503A (en) | 2002-04-23 |
WO1998024905A2 (en) | 1998-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998007859A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998017687A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1997007198A3 (en) | Dna sequences and secreted proteins encoded thereby | |
WO1999057132A8 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998033916A8 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998004693A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998042741A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998042739A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998055614A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998040486A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998005776A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998027205A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1999058642A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998046757A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998037094A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998032853A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998040404A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998056909A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998021332A3 (en) | Secreted proteins and polynucleotides encoding them | |
AU2459397A (en) | Secreted proteins and polynucleotides encoding them | |
WO1998030589A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998041539A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998001553A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998001554A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998001552A3 (en) | Secreted proteins and polynucleotides encoding them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2273845 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997951549 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997951549 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997951549 Country of ref document: EP |